MRF-Funded Research Enters Phase 1 Clinical Trial Examining Myelin Regenerative Benefits of Mesenchymal Stem Cells for Potential Multiple Sclerosis Treatment SARATOGA, Calif.--(BUSINESS WIRE)--The ...

PALO ALTO, May 27, 2014 — Bionure Inc. today announced its drug candidate, BN201, was shown to promote myelination — the cellular process of repairing the protective sheath surrounding nerves that is ...

The (MRF) today announced the launch of its internship program assessing the drug discovery decision-making process in Phase III clinical trial failures. Twenty-six participating graduate students ...

SARATOGA, Calif. and MEQUON, Wis., Feb. 8, 2012 /PRNewswire/ -- The Myelin Repair Foundation (MRF) and ENDECE Neural, LLC have formed a partnership to expedite the advancement of myelin regeneration ...

When Scott Johnson was diagnosed with multiple sclerosis at age 20, he didn’t let it impede his career. He became a business management consultant, heading three start-ups. Then in 2002, his disease ...

Scott Johnson is a man in a hurry to discover a cure for multiple sclerosis (MS). If he succeeds, the founder and president of the Myelin Repair Foundation, of Saratoga, Calif., will have conquered ...

The goal is to advance firm’s Phase II compound, but findings can be used in diagnostic and drug development as well. Opexa Therapeutics established a research partnership with the Myelin Repair ...

Scott Johnson may have dreamed up the prototype for all biotech startups to come. When he formed the Myelin Repair Foundation to come up with a cure for multiple sclerosis (myelin is the fatty sheath ...

On Monday, the Saratoga-based not-for-profit Myelin Repair Foundation announced that it will close Aug. 31. The foundation, which funded academic research on multiple sclerosis, said it struggled to ...

A new trend in research funding has emerged: directed philanthropy, in which the donor plays an active, hands-on role in managing the research by applying a “business model.” Although such efforts now ...

The scenario: A widespread contamination triggered a neurological disease that could infect as many as 100 million people in the U.S. What do we do? The Breakthroughs to Cures game generates over ...